Market Overview

15 Biggest Mid-Day Losers For Friday

  • Finisar Corporation (NASDAQ: FNSR) shares dropped 19.4 percent to $28.12 after the company reported weaker-than-expected results for its third quarter and issued disappointing forecast for the current quarter.
  • Ocera Therapeutics Inc (NASDAQ: OCRX) shares tumbled 19.1 percent to $1.53. Ocera Therapeutics reported a Q4 loss of $0.22 per share.
  • Inseego Corp (NASDAQ: INSG) dropped 19 percent to $2.31. Inseego posted a wider-than-expected quarterly loss.
  • Mueller Industries, Inc. (NYSE: MLI) shares fell 18.3 percent to $31.78.
  • TearLab Corp (NASDAQ: TEAR) shares declined 17.6 percent to $3.88. Tearlab reported a Q4 loss of $0.81 per share on revenue of $7.121 million. The company also disclosed that it has begun process to explore strategic alternatives.
  • Zumiez Inc. (NASDAQ: ZUMZ) tumbled 13.2 percent to $18.23. Zumiez posted upbeat results for its fourth quarter. However, the company issued a downbeat guidance for the current quarter.
  • CECO Environmental Corp. (NASDAQ: CECE) dropped 13.3 percent to $10.19. CECO Environmental reported Q4 adjusted earnings of $0.35 per share on revenue of $100 million.
  • Smith Micro Software, Inc. (NASDAQ: SMSI) fell 12.9 percent to $1.18 on downbeat quarterly results.
  • Second Sight Medical Products Inc (NASDAQ: EYES) shares declined 12.3 percent to $1.36. Second Sight reported a Q4 adjusted loss of $0.17 per share.
  • MeetMe Inc (NASDAQ: MEET) dropped 11.2 percent to $5.16. MeetMe reported an offering of common shares.
  • Ionis Pharmaceuticals Inc (NASDAQ: IONS) shares dipped 10.4 percent to $41.02. Goldman Sachs downgraded Ionis Pharmaceuticals from Neutral to Sell.
  • Sears Hometown and Outlet Stores Inc (NASDAQ: SHOS) dropped 9.6 percent to $3.30. Sears Hometown reported a Q4 loss of $45.8 million.
  • Surgery Partners Inc (NASDAQ: SGRY) declined 8.7 percent to $19.12 after the company posted weaker-than-expected quarterly profit.
  • Alexandria Real Estate Equities Inc (NYSE: ARE) fell 4.2 percent to $108.98. Alexandria Real Estate Equities priced public offering of 6.1 million shares of common stock at $108.55 per share.
  • Cara Therapeutics Inc (NASDAQ: CARA) fell 3.7 percent to $16.85 after the company reported a wider-than-expected quarterly loss.

Latest Ratings for FNSR

Dec 2018DowngradesBuyHold
Dec 2018DowngradesBuyNeutral
Dec 2018MaintainsEqual-WeightEqual-Weight

View More Analyst Ratings for FNSR
View the Latest Analyst Ratings

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings


Related Articles (ARE + CARA)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

CARBO Ceramics Showing Several Signs Of A Good Short Story

Alphabet Makes New All-Time High